HDFC Pharma and Healthcare Fund(G)-Direct Plan
+28.42%
3Y annualised
+28.42%
3Y annualised
+0.03% 1D
Expert Rating Locked 🔒
Subscribe to unlock the ratings
- Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Mattis eget etiam curabitur a cras malesuada pulvinar.
Buy, Hold or Sell?
Unlock our SEBI-RIA verdict on this fund.
NAV : 16 Oct 2026
₹21.23
Min. SIP amount
₹100
Fund size (AUM)
3501 Cr
Expense ratio
0.92%
Launched on
04 Oct 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
NAV : 16 Oct 2026
₹21.23
Min. SIP amount
₹100
Fund size (AUM)
3501 Cr
Expense ratio
0.92%
Launched on
04 Oct 2023
Lock-in period
N/A
Benchmark
Nifty 50
Fund Plan
Direct
SIP Calculator + Returns
Monthly investment
₹8,000
Stock Allocation
Fund Composition
Large Cap
35.95%
Mid Cap
22.44%
Small Cap
35.00%
Others
6.60%
Sector Allocation
Healthcare
87.39%
Domestic Equities
7.82%
Cash & Cash Equivalents And Net Assets
3.23%
Trading
1.56%
Minimum investments
Returns vs rankings
Exit load, stamp duty and tax
Exit load
1% on or before 30D, Nil after 30D
No exit load after holding period
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within less than 1 year, returns are taxed as per your Income Tax slab. If you redeem after more than 1 year, returns are taxed at 12.5%.
Fund management
Nikhil Mathur
Present
Similar/Peer Fund Comparison
ICICI Pru Strategic Metal and Energy Equity FoF(G)-Direct Plan
ICICI Pru US Bluechip Equity Fund(G)-Direct Plan
Kotak Healthcare Fund(G)-Direct Plan
Motilal Oswal Active Momentum Fund(G)-Direct Plan
HDFC Pharma and Healthcare Fund(G)-Direct Plan
SBI Automotive Opportunities Fund(G)-Direct Plan
Edelweiss Recently Listed IPO Fund(G)-Direct Plan
Quant ESG Integration Strategy Fund(G)-Direct Plan
FAQs
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.